J Kastelein

2.4k citations

43 papers · 1.6k indexed · h-index 15

Surgery top 5%
Cardiology and Cardiovascular Medicine top 5%
Endocrinology, Diabetes and Metabolism top 2%
Physiology top 5%
Molecular Biology

Co-authors: Ton J. Rabelink Willem Erkelens Francesco Cosentino Robert Wever H A Koomans Erik S.G. Stroes Thomas F. Lüscher Jan Albert Kuivenhoven
Topics: Lipoproteins and Cardiovascular Health (21 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers)Cancer, Lipids, and Metabolism (8 papers)
Cited by: Endocrinology, Diabetes and Metabolism Cardiology and Cardiovascular Medicine Biochemistry
Journals: Journal of Clinical Investigation European Heart Journal Arteriosclerosis Thrombosis and Vascular Biology
Partner nations: Netherlands United States Canada

In The Last Decade

J Kastelein

41 papers receiving 1.5k citations

Peers

Countries citing papers authored by J Kastelein

Since Specialization

Citations

This map shows the geographic impact of J Kastelein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Kastelein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Kastelein more than expected).

Fields of papers citing papers by J Kastelein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Kastelein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Kastelein. The network helps show where J Kastelein may publish in the future.

Co-authorship network of co-authors of J Kastelein

This figure shows the co-authorship network connecting the top 25 collaborators of J Kastelein. A scholar is included among the top collaborators of J Kastelein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Kastelein. J Kastelein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL-clearance and regress atherosclerosis on atorvastatin background 2026 ·Journal of Lipid Research ·(unknown),(unknown),Nanda Keijzer,(unknown),(unknown),(unknown),(unknown),(unknown),J Kastelein,(unknown),Anita M. van den Hoek,Geurt Stokman,Elsbet Pieterman,(unknown)	0
2	Efficacy of obicetrapib across the spectrum of background lipid-lowering therapies: pooled analyses of the BROADWAY and BROOKLYN randomized trials 2025 ·European Journal of Preventive Cardiology ·(unknown),(unknown),(unknown),Marc Ditmarsch,Douglas Kling,(unknown),J Kastelein,(unknown),(unknown)	0
3	Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein 2013 ·European Heart Journal ·Vincenzo Sorrentino,(unknown),M. Mahdi Motazacker,Jessica K. Nelson,Joep C. Defesche,Geesje M. Dallinga‐Thie,J Kastelein,G. Kees Hovingh,Noam Zelcer	45
4	Assessment of atherosclerosis: the role of flow-mediated dilatation 2010 ·European Heart Journal ·Marietta Charakida,Stefano Masi,Thomas F. Lüscher,J Kastelein,John Deanfield	217
5	The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis? 2010 ·Journal of Endocrinology ·Anne Q. Reuwer,Marco van Eijk,(unknown),Chris M. van der Loos,(unknown),(unknown),J Kastelein,Jörg Hamann,Vincent Goffin,Jan H. von der Thüsen,(unknown),Jan Aten	44
6	Abstract: 1024 THE DYSLIPIDEMIA OF MOTHERS WITH FAMILIAL HYPERCHOLESTEROLEMIA DETERIORATES LIPID LEVELS IN THEIR ADULT OFFSPRING 2009 ·Atherosclerosis Supplements ·(unknown),(unknown),Daniel Gaudet,Diane Brisson,Suthesh Sivapalaratnam,(unknown),(unknown),J Kastelein,(unknown)	1
7	Abstract: P870 IDENTIFICATION OF APOB AND PCSK9 MUTATIONS CAUSING A NON-ADH PHENOTYPE IN MOLECULAR DIAGNOSED ADH PATIENTS 2009 ·Atherosclerosis Supplements ·Sigrid W. Fouchier,Roeland Huijgen,(unknown),Joep C. Defesche,J Kastelein	2
8	[The practice guideline 'Diagnosis and treatment of familial hypercholesterolaemia' of the Dutch Health Care Insurance Board]. 2006 ·PubMed ·Edmond Walma,Frank L.J. Visseren,J. Wouter Jukema,J Kastelein,A.W. Hoes,Anton F. H. Stalenhoef	26
9	Carotid and femoral B-mode ultrasound intima-media thickness measurements in adult post-coarctectomy patients. 2004 ·PubMed ·(unknown),Eric de Groot,J Kastelein,B. J. M. Mulder	8
10	Parental attitude towards genetic testing for familial hypercholesterolaemia in children [electronic letter] 2002 ·Journal of Medical Genetics ·M.A.W. Umans-Eckenhausen,Frans J. Oort,(unknown),(unknown),J Kastelein,J.C.J.M. de Haes	5
11	Review of first 5 years of screening for familial hypercholesterolemia in The Netherlands 2001 ·ACC Current Journal Review ·M.A.W. Umans-Eckenhausen,(unknown),Eric J.G. Sijbrands,(unknown),J Kastelein	10
12	[Higher prevalence of familial hypercholesterolemia than expected in adult patients of four family practices in Netherlands]. 2000 ·PubMed ·Peter Lansberg,(unknown),Marcel A. van de Ree,(unknown),J Kastelein	33
13	Activation of the Contact System of Coagulation Does Not Contribute to the Hemostatic Imbalance in Hypertriglyceridemia 1999 ·Arteriosclerosis Thrombosis and Vascular Biology ·Monique C. Minnema,M. E. Wittekoek,Niki S.M. Schoonenboom,J Kastelein,C. Erik Hack,Hugo Ten Cate	10
14	Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB. 1997 ·Journal of Clinical Investigation ·Ytje Y. van der Hoek,Arno Lingenhel,H.G. Kraft,Joep C. Defesche,J Kastelein,Gerd Utermann	13
15	Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. 1997 ·Journal of Clinical Investigation ·Erik S.G. Stroes,J Kastelein,Francesco Cosentino,Willem Erkelens,Robert Wever,H A Koomans,Thomas F. Lüscher,Ton J. Rabelink	465
16	The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes 1997 ·Journal of Lipid Research ·Jan Albert Kuivenhoven,Haydn Pritchard,John S. Hill,J. Frohlich,Gerd Assmann,J Kastelein	278
17	Short-Term Efficacy and Safety of Pravastatin in 72 Children with Familial Hypercholesterolemia 1996 ·Pediatric Research ·H.C. Knipscheer,C Boelen,J Kastelein,D.E. van Diermen,Björn E. Groenemeijer,A. van den Ende,Harry R. Büller,H. D. Bakker	124
18	Lipoprotein [a] 1996 ·Advances in clinical chemistry ·A. van den Ende,Ytje Y. van der Hoek,J Kastelein,Marlys L. Koschinsky,(unknown),(unknown)	6
19	Fish Eye Disease and LCAT-deficiency, extremes of one phenotype. A novel LCAT-mutation in a large family of Dutch descent 1994 ·Atherosclerosis ·J.A. Kuivenhoven,Heiko Wiebusch,(unknown),John S. Hill,P. Haydn Pritchard,Harald Funke,J Kastelein	2
20	The prediction of the therapeutic response to cholesterol lowering drugs in an 11‐year‐old boy with homozygous familial hypercholesterolaemia 1991 ·Journal of Inherited Metabolic Disease ·H. D. Bakker,T. Bruin,M. C. L. Schaap,Peter Lansberg,J Kastelein	2

About J Kastelein

J Kastelein is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 43 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (21 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Cancer, Lipids, and Metabolism (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (470 citations), Cardiology and Cardiovascular Medicine (509 citations) and Biochemistry (161 citations). J Kastelein has collaborated with scholars based in Netherlands, United States and Canada. Frequent co-authors include Ton J. Rabelink, Willem Erkelens, Francesco Cosentino, Robert Wever, H A Koomans, Erik S.G. Stroes, Thomas F. Lüscher, Jan Albert Kuivenhoven, John S. Hill and J. Frohlich. Their work appears in journals such as Journal of Clinical Investigation, European Heart Journal and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact